Skip to content

Sleep Ergonomics in Low Back Pain

The Effect of Sleep Ergonomics on Pain Low Back Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03342885
Acronym
SLEEPLBP
Enrollment
120
Registered
2017-11-17
Start date
2017-10-03
Completion date
2019-12-31
Last updated
2017-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Low Back Pain, Sleep ergonomics

Brief summary

The aim of this study is to investigate the effect of sleep ergonomics guidance given by physiotherapist on pain and disability in patients with low back pain. In this randomized controlled trial participants are assigned either into the intervention or the control group. The intervention group will receive detailed instruction on sleeping ergonomics whereas the control group will only be instructed to avoid painful sleeping posture. The initial hypothesis is that in the intervention group pain and disability will decrease more compared to the control group.

Interventions

BEHAVIORALSpecific sleep ergonomics guidance

Participants receive a detailed instruction in sleep ergonomics. Participants are instructed to maintain either side lying or supine sleeping posture, depending on which is less painful. Neutral position of spine supported by specific placement of body pillow. Changing of posture during sleep is prevented. The participants are recommended to replace their mattress if they feel that it is too hard or too soft. Instruction is given by a physiotherapist during one personal therapy session and the participants also receive a printed instruction.

BEHAVIORALGeneral sleep ergonomics guidance

Participants are instructed find most comfortable sleeping posture by personal preference and to avoid painful posture. The participants are recommended to replace their mattress if they feel that it is too hard or too soft. Instruction is given by a physiotherapist during one personal therapy session and the participants also receive a printed instruction.

Sponsors

Central Finland Hospital District
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Low Back Pain * Pain during sleep or

Exclusion criteria

* Fibromyalgia * Inflammatory rheumatic disease * Severe depression or other psychiatric diagnosis * Previously received specific guidance in sleep ergonomics

Design outcomes

Primary

MeasureTime frameDescription
Pain Visual Analog Scale (VAS)Change from baseline to 12 month follow-upLow back pain reported with Visual Analog Scale (VAS) during rest, after getting up and during day; 0-100 mm scales, 0 mm = no pain, 100 mm = worst possible pain. Change from baseline to 12 month follow-up is reported in mm for each sub-scale (during rest, after getting up and during day).
Oswestry Disability Index (ODI) scoreChange from baseline to 12 month follow-upOswestry Disability Index Finnish version 2.0 total score (scale 0-100%): 0 = minimal disability, 100 = bed-bound or exaggeration of symptoms; and sub-scores (scale 0-5): 0 = minimal disability, 5 = worst disability. Change is reported for total ODI score and sub-scores from baseline to 12 month follow-up.

Secondary

MeasureTime frameDescription
Reported amount of sleepChange from baseline to 12 month follow-upPerceived sufficiency of sleep based on question: Do you feel that you have got sufficient sleep during last week?, reported with 5 step Likert scale (scale 1-5), 1 = not sufficient at all, 5 = totally sufficient. Change in perceived sufficiency of sleep is reported from baseline to 12 month follow-up.
Number of sick leave daysChange from baseline to 12 month follow-upNumber of sick leave days during last 12 months as reported by the participant. Change in sick leave days during last 12 months is reported from baseline to 12 month follow-up.

Countries

Finland

Contacts

Primary ContactJuhani Multanen, PhD
juhani.multanen@ksshp.fi35850 555 1933

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026